Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-13 7:21 pm Purchase |
2024-05-09 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 10,677,973 69.500% |
1,824,800 (+20.61%) |
Filing History |
| 2024-05-07 7:46 pm Purchase |
2024-05-03 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 8,853,173 65.400% |
4,748,335 (+115.68%) |
Filing History |
| 2024-04-19 4:31 pm Purchase |
2024-04-12 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 4,104,838 46.680% |
4,104,838 (New Position) |
Filing History |
| 2024-03-15 5:00 pm Purchase |
2024-03-07 | 13G | Avinger, Inc. AVGR |
CR Group L.P. | 150,545 9.900% |
150,545 (New Position) |
Filing History |
| 2023-08-14 3:22 pm Purchase |
2023-08-04 | 13G | Avinger, Inc. AVGR |
CR Group L.P. | 178,944 19.900% |
178,944 (New Position) |
Filing History |
| 2023-07-13 3:58 pm Purchase |
2023-07-03 | 13G | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 725,036 19.900% |
725,036 (New Position) |
Filing History |
| 2021-01-06 4:15 pm Sale |
2020-12-31 | 13G | Assertio Holdings, Inc. ASRT |
CR Group L.P. | 72,787 0.300% |
-1,500,000 (-95.37%) |
Filing History |
| 2020-12-30 4:19 pm Sale |
2020-12-23 | 13G | Assertio Holdings, Inc. ASRT |
CR Group L.P. | 1,572,787 5.600% |
-2,816,796 (-64.17%) |
Filing History |